Pharmanutra S.P.A. Announces New Distribution Agreements in Indonesia, Kuwait and Mexico
usership of 275 million inhabitants. As regards Kuwait, the agreement concluded with PharmaLife Co., a company that distributes medical devices, food supplements, medical equipment and natural products is particularly relevant becausePharmaLife Co. will be placing five PharmaNutra products and one Junia Pharma product on the market, specifically: Cetilar(R) Cream, Cetilar(R) Patch, SiderAL(R) Folic 20 sticks, SiderAL(R) Folic 30 cps, SiderAL(R) Forte Int 20 cps and SiderAL(R) Gocce P. In Mexico, PharmaNutra has finalised a new partnership with the company SMS Pharma, whose core business focuses on developing national sales networks specialising in the distribution of pharmaceutical and health products. The contract with SMS Pharma will result, in the course of 2023, in the marketing of the nutritional supplements SiderAL(R) Forte 15mg 30 cps and SiderAL(R) Folic 21 mg 20 sticks (PharmaNutra), as well as SiderAL(R) Gocce P (Junia Pharma) throughout Mexico. With the conclusion of these new distribution agreements, the PharmaNutra Group can now count on 47 distributors in 70 countries across Europe, Asia, Latin America and Africa.